Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.

Annals of neurology·2003

Same author

Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.

The European journal of neuroscience·2002

Same author

Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease.

Progress in brain research·2002

Same author

Proteasome inhibition causes nigral degeneration with inclusion bodies in rats.

Neuroreport·2002

Same author

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.

Proceedings of the National Academy of Sciences of the United States of America·2002

Search research articles

Related Experiment Video

Updated: May 28, 2026

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

Stem cell therapy for Parkinson's disease.

Lars M Björklund¹

¹Center for Genomics and Bioinformatics, Karolinska Institutet, Stockholm, Sweden.

Dialogues in Clinical Neuroscience

|October 29, 2011

Summary

This summary is machine-generated.

Human fetal dopamine neuron transplants for Parkinson's disease (PD) showed long-term survival and symptom relief. However, ethical and technical issues halted clinical use, prompting research into stem cells for safer neuronal replacement.

Keywords:

differentiation dopamine embryonic stem cell neural progenitor neurogenesis ventral mesencephalon

More Related Videos

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Related Experiment Videos

Last Updated: May 28, 2026

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Area of Science:

Neuroscience
Regenerative Medicine
Cell Therapy

Background:

Human fetal dopamine (DA) neuron transplantation demonstrated proof-of-principle for Parkinson's disease (PD) treatment, showing long-term survival and functional integration.
Despite initial success, ethical concerns, technical challenges, and adverse grafting-related side effects have impeded widespread clinical application of fetal cell therapy for PD.

Purpose of the Study:

To review the efficacy and limitations of fetal DA neuron transplantation in PD.
To explore the potential of stem cell biology and adult neurogenesis for future PD therapies.

Main Methods:

Review of existing clinical data and research on fetal cell transplantation for PD.
Analysis of advancements in stem cell biology and neurogenesis research relevant to neuronal replacement.

Main Results:

Fetal DA neuron grafts can survive for over a decade and provide significant symptomatic relief in PD patients.
Limitations include ethical considerations, technical difficulties, and graft-related side effects, restricting clinical adoption.

Conclusions:

While fetal cell transplantation offers a proof-of-concept, its clinical utility is limited.
Advances in stem cell research offer promising avenues for developing safer and more effective cell-based therapies for Parkinson's disease.